Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. DOL:CN
10. NDAQ

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 16.52 +0.72 (4.56%)
Previous Close $15.80    52 Week High $12.48 
Open $15.56    52 Week Low $1.60 
Day High $16.61    P/E N/A 
Day Low $15.51    EPS $-6.33 
Volume 702,837